Observations in tissues of primary ovarian cancer revealed that the FA gene FANCF was methylated in 21% of the tissues examined, and it was hypothesized that the disruption of the FA/BRCA pathway might contribute to the initial sensitivity toward cisplatin. The gene discussed is FANCF; the disease is ovarian carcinoma.